"Vaccine Taskforce" from_date:2012

12 resultsPro users have access to +0 Systematic Reviews

Filter Results
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
                    • Pro

                            Clinical Area Pro

                            Further Refinement
                            User Guide

                            User Guide

                            1
                            2022Med Check - The Informed Prescriber
                            of Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, discussed it in the 31st Health Sciences Council Vaccine Taskforce (3-24-2022) as follows [14]. There is an immune phenomenon called “original antigenic sin” in English. I think this is the state of immunity given by vaccines etc. with conventional strains, and I think
                            Subscribe to Trip PRO for an enhanced experience
                            • Access to millions of Full-text articles where avaliable
                            • Unlock 100,000+ extra articles with Systematic Reviews
                            • Further Filtering Options
                            • No adverts
                            • Advanced Search Ability
                            • Enhanced SmartSearch showing unlimited related articles
                            Read more about Trip PRO
                            4
                            2021The Health Foundation
                            into care homes the impact can be devastating’.133COVID-19 vaccinesThe COVID-19 vaccination programme has been central to the government’s pandemic response and a broad success so far.134 A vaccine taskforce was established by government in April 2020 and the first vaccine was approved on 2 December 2020.135 Many people receiving social care were prioritised by government and vaccinated quickly,* though
                            6
                            in schedules with BNT162b2 as a second dose and higher humoral immunogenicity in homologous schedules, but overall lower T-cell responses across all schedules. Future vaccines using these novel platforms might benefit from schedules with long intervals. UK Vaccine Taskforce and National Institute for Health and Care Research.
                            7
                            2022Nature Medicine
                            and efficacy testing of forthcoming interventions, 36 volunteers aged 18-29 years without evidence of previous infection or vaccination were inoculated with 10 TCID of a wild-type virus (SARS-CoV-2/human/GBR/484861/2020) intranasally in an open-label, non-randomized study (ClinicalTrials.gov identifier NCT04865237 ; funder, UK Vaccine Taskforce). After inoculation, participants were housed in a high
                            11
                            2012Wikipedia
                            the COVID-19 pandemic, in autumn 2020 the committee gave advice to the recently formed Vaccine Taskforce on the groups of people that should be prioritised for vaccination, giving regard to health inequalities.[16][17] Their advice was refined in December of that year.[18]On 6 April 2021, Maggie Wearmouth of the JCVI said "in a personal capacity" that the vaccine roll-out should be slowed "in younger